Volution Immuno Pharmaceuticals' Reverse Merger Round

Volution Immuno Pharmaceuticals raised a round of funding on July 13, 2015. Investors include Akari Therapeutics.

Volution Immuno Pharmaceuticals (VIP) is a private, Swiss-based, clinical stage biotechnology company.…

Articles about Volution Immuno Pharmaceuticals' Reverse Merger Round: